Amit Bansal, Rusan Pharma Under ED Scanner for BNX Drug Misuse

Directorate of Enforcement (ED), Jalandhar, has conducted search operations on
18.07.2025 at 4 locations at Chandigarh, Ludhiana, Barnala and Mumbai under the
provisions of Prevention of Money Laundering Act (PMLA), 2002 in connection with a money
laundering investigation connected with illegal sale of BNX (Buprenorphine/Nalaxone) drugs
by 22 private de addiction centres in Punjab. These drugs are used for rehabilitation of drug
addicts but has also been misused for substance abuse. The search operation covered
office and residential premises linked to Amit Bansal, Rusan Pharma Limited and drug
inspector Roop Preet Kaur.
ED initiated money-laundering investigation on the basis of various FIRs registered
by Punjab Police under sections of NDPS Act 1985 and Prevention of Corruption Act, 1988.
ED investigation revealed that Amit Bansal was procuring BNX drugs in the guise of
his 22 de-addiction centers and selling the same illegally, thereby generating huge Proceeds
of Crime (POC). The drug shortage because of the illegal sale was allegedly shown as
purchase return. The POC, thus generated, was layered through bank accounts and used
in purchase of multiple immovable properties.
During the course of search, various incriminating records, including medicine stock
register, multiple property purchase agreements and other relevant evidences critical in
establishing the financial trail and uncovering the modus operandi of the entities involved
were recovered and seized.

Thank you for reading this post, don't forget to subscribe!